Tag Archives: Eli Lilly

Traditional vs. Digital, or
Integrate! Integrate! Integrate!

By Brittany Agro | Published: February 11, 2009
Can pharma rely on one agency to create both its traditional and its interactive advertising? Or is there a “best agency model” (pure digital, digital group within larger holding company, or a mixture of both) that industry can follow? This was the question addressed by four panelists today at the ePharma Summit in Philadelphia. Bill [...]
Posted in Advertising, E-Media, Marketing | Also tagged , , , , | 5 Comments

Lilly Puts Up $6.5 Billion for ImClone

By George Koroneos | Published: October 6, 2008
Lilly broke the news Monday morning that ImClone had accepted its offer to acquire the biotech firm for $6.5 billion or $70 per share—Lilly’s largest acquisition ever. With this purchase Lilly gains control of ImClone’s blockbuster, targeted cancer agent Erbitux, which is marketed for second- and third-line colon cancer and refractory head and neck cancer. ImClone also [...]
Posted in Biotech, Deals | Also tagged , , , , , , , | 1 Comment